Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc treatment method for tinnitus patients.

Información del proyecto

Tinnitus Platform

Identificador del acuerdo de subvención: 761940

DOI

10.3030/761940

Proyecto cerrado

Fecha de la firma de la CE 29 Enero 2017

Fecha de inicio 1 Febrero 2017

Fecha de finalización 31 Mayo 2017

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

KINETIC CENTRUM NOWOCZESNEJ AUDIOLOGII SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
Poland

Objetivo

Meeting demand for the first medical device for diagnosis and therapy of tinnitus is set to be a crucial challenge for future audiology and neurology. For that reason Kinetic Center of Advanced Audiology (www.kinetic-cna.pl/) aims to commercialize technologies for the Tinnitus examination and treatment. To do so, co-founders rely on their extensive experience and the interdisciplinary team of: audiologists, laryngologists, medical technicians, neurobiologists, neuroscientists, musical trainers, hearing care professionals, clinicians and nutritionists.
Our main objective today is to bring to the global market a novel “Tinnitus Diagnostic Platform” which is a IT platform of multiple test, that can give more information and indicate with more precision the nature of the tinnitus and “Synaptic adaptation Arc therapy” which is dedicated for tinnitus patients after sudden hearing loss. We have conducted preliminary research studies on a small group of around 200 patients and the promising results encouraged us to demonstrate clinical effectiveness of our solution on n a bigger number of subjects.
The key market application of Tinnitus Diagnostic Platform is to differentiate the pathology of hearing and finally to select appropriate treatment. Synaptic adaptation Arc therapy is based on continuous acoustic stimulation which enforces activity of hear cells and nervous system and gives opportunity to release Arc/Arg 3.1 protein that rebuild synapses. The project addresses the problem of lack of medical device for tinnitus diagnosis and very poor research on the course of the condition.
Finally, to fully exploit and to commercialize this new and EU-based technology, we want to open new Advanced Audiology Clinics around Europe to propose complex methods on hearing pathologies. The Future growth will be driven through sales of Tinnitus Diagnostic Platform to other Audiology Clinics (B2B) and sales of Synaptic adaptation Arc therapy treatment set to patients (B2C).

Ámbito científico (EuroSciVoc)

• ciencias médicas y de la salud › medicina clínica › otorrinolaringología

Programa(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being PROGRAMA PRINCIPAL
  
• H2020-EU.3.1.4. - Active ageing and self-management of health
  
• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
  
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
  
• H2020-EU.3.1.6. - Health care provision and integrated care
  

Tema(s)

• SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
  

Régimen de financiación

SME-1 - SME instrument phase 1

Convocatoria de propuestas

H2020-SMEInst-2016-2017

Coordinador

KINETIC CENTRUM NOWOCZESNEJ AUDIOLOGII SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA

• Aportación neta de la UEn: € 50 000,00
• Dirección: UL. ZURAWIA 43 ; 00 680 WARSZAWA ; Polonia
• Pyme Sí:
  Región
  Makroregion województwo mazowieckie › Warszawski stołeczny › Miasto Warszawa
• Región: Makroregion województwo mazowieckie › Warszawski stołeczny › Miasto Warszawa
• Tipo de actividad: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Coste total: € 71 429,00